These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 25216204)

  • 41. Clinical guidelines of the Italian Society of Periodontology for the reconstructive surgical treatment of angular bony defects in periodontal patients.
    Pagliaro U; Nieri M; Rotundo R; Cairo F; Carnevale G; Esposito M; Cortellini P; Pini-Prato G;
    J Periodontol; 2008 Dec; 79(12):2219-32. PubMed ID: 19053910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects.
    Pradeep AR; Shetty SK; Garg G; Pai S
    J Periodontol; 2009 Jan; 80(1):62-71. PubMed ID: 19228091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of biologics for the treatment of periodontal infrabony defects: An American Academy of Periodontology best evidence systematic review and network meta-analysis.
    Tavelli L; Chen CJ; Barootchi S; Kim DM
    J Periodontol; 2022 Dec; 93(12):1803-1826. PubMed ID: 36279121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: a randomized trial.
    Ogihara S; Tarnow DP
    J Periodontol; 2014 Oct; 85(10):1351-60. PubMed ID: 24660759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of platelet-rich plasma on clinical outcomes of the surgical treatment of periodontal intrabony defects: A systematic review and meta-analysis.
    Hou X; Yuan J; Aisaiti A; Liu Y; Zhao J
    BMC Oral Health; 2016 Aug; 16(1):71. PubMed ID: 27531202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions.
    Rosen PS; Reynolds MA
    J Periodontol; 2002 Aug; 73(8):942-9. PubMed ID: 12211505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
    Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
    J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review.
    Sculean A; Nikolidakis D; Nikou G; Ivanovic A; Chapple IL; Stavropoulos A
    Periodontol 2000; 2015 Jun; 68(1):182-216. PubMed ID: 25867987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.
    Graziani F; Gennai S; Cei S; Ducci F; Discepoli N; Carmignani A; Tonetti M
    J Clin Periodontol; 2014 Apr; 41(4):377-86. PubMed ID: 24329867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of autogenous platelet concentrate on combined GTR/graft therapy in intrabony defects: a 7-year follow-up of a randomized prospective clinical split-mouth study.
    Moder D; Taubenhansl F; Hiller KA; Schmalz G; Christgau M
    J Clin Periodontol; 2012 May; 39(5):457-65. PubMed ID: 22486272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of demineralized freeze-dried bone allograft with and without concentrated growth factor membrane in the treatment of periodontal intrabony defects: a randomized controlled clinical trial.
    Samarth G; Kolte A; Kolte R; Bajaj V
    Clin Oral Investig; 2023 Apr; 27(4):1645-1657. PubMed ID: 36441270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Periodontal regeneration - furcation defects: a systematic review from the AAP Regeneration Workshop.
    Avila-Ortiz G; De Buitrago JG; Reddy MS
    J Periodontol; 2015 Feb; 86(2 Suppl):S108-30. PubMed ID: 25644295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
    Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
    J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of 2 regenerative procedures--guided tissue regeneration and demineralized freeze-dried bone allograft--in the treatment of intrabony defects: a clinical and radiographic study.
    Parashis A; Andronikaki-Faldami A; Tsiklakis K
    J Periodontol; 1998 Jul; 69(7):751-8. PubMed ID: 9706851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.